我要投票 健恒药业在兽药行业中的票数:565
· 外 推 电 报 ·
2026-01-09 09:13:16 星期五

【健恒药业是哪个国家的品牌?】

健恒药业是什么牌子?「健恒药业」是 河南健恒动物药业有限公司 旗下著名品牌。该品牌发源于河南省郑州市,由创始人朱红标在2011-04-27期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力健恒药业品牌出海!将品牌入驻外推网,定制健恒药业品牌推广信息,可以显著提高健恒药业产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

健恒药业是一家科技密集型企业,以开发中华瑰宝中药为核心业务,中草药的种植、开发、生产、使用全程环保、无公害。让养殖业健康成长是企业的愿景。

健恒药业成立以来,以“渴望产生力量”为品牌核心诉求,坚持以“健康·恒久远”为品牌核心理念,服务客户,服务社会;公司在药物研发领域大胆引进专业人才;企业成立“健恒兽药技术研发中心”与“禽病诊断中心”,用于解决市场上的疑难杂症及热点疾病的诊断与化验,更好地为广大客户提供支持。

健恒产品始终坚持以中药为突破口,大力弘扬国粹之精华,位于中牟新区农业示范园的中药种植基地也是公司向制药源头的一个延伸。健恒专家组经过多年潜心研发,不断总结,在市场上逐渐形成以“固元康”、“金呼克”、“氟来欣”、“菌克”、“平安精华素”、“替福星”、“健特美”等品牌畜禽药产品,质量稳定,疗效确切。

健恒人的使命是:聚焦客户关注的挑战和压力、提供有竞争力的用药解决方案和技术支持,持续为客户创造价值。健恒人以开放、创新、守信的品格与广大客户共同发展、携手共赢。


英文翻译:Jianheng pharmaceutical is a science and technology intensive enterprise, which takes the development of Chinese precious traditional Chinese medicine as its core business. The cultivation, development, production and use of Chinese herbal medicine are environmentally friendly and pollution-free. Let the breeding industry grow healthily is the vision of the enterprise. Since the establishment of Jianheng Pharmaceutical Co., Ltd., with "desire to produce strength" as the core demand of the brand, and with "health and eternity" as the core concept of the brand, the company has served customers and the society; the company has boldly introduced professional talents in the field of drug research and development; the company has established "Jianheng veterinary drug technology research and development center" and "poultry disease diagnosis center" to solve the difficult and hot diseases in the market The diagnosis and test, to better support our customers. Jian Heng products always adhere to the breakthrough point of traditional Chinese medicine and vigorously carry forward the essence of quintessence. The traditional Chinese medicine planting base located in the agricultural demonstration garden of Zhongmu new area is also an extension of the company to the source of medicine. After years of painstaking research and development, the health experts group has gradually concluded that the brand products of livestock and poultry products, such as "solid Yuan Kang", "Jin Hu Ke", "fluoroxin", "mushroom", "safe essence", "Fuxing" and "Jian Tai Mei", are gradually stable in the market. Our mission is to focus on the challenges and pressures of our customers, provide competitive pharmaceutical solutions and technical support, and continue to create value for our customers. With the character of openness, innovation and faithfulness, Jianheng people develop together with our customers and win-win together.

本文链接: https://www.waitui.com/brand/5a955b645.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

华纳兄弟探索公司拒绝派拉蒙,坚持与Netflix的交易

华纳兄弟探索公司敦促股东拒绝派拉蒙的敌意收购,并重申其将工作室和流媒体资产出售给Netflix的协议是更优报价,且完成路径更明确。(新浪财经)

2小时前

Grok因涉性图像面临审查

埃隆·马斯克麾下未上市企业xAI在其Grok模型被用于生成涉性图像(包括未成年人图像)后受到抨击,这引发了监管机构对该与X平台集成的工具的调查和政策质疑。(新浪财经)

2小时前

保险公司发债规模连续三年超千亿元,多重因素推动

连续三年,保险公司发行债券规模超千亿元。刚刚过去的2025年,23家保险公司发债规模合计达1042亿元。业内人士普遍认为,这背后有多重推动因素——低利率周期下,保险公司普遍面临较高的资本补充需求;利率下行,发债成本更低,险企有动力发新债置换旧债;也有险企希望在利率低位时融资以进一步夯实资本实力、增厚发展安全垫。另外,在逆周期监管思路下,保险公司发债也在一定程度上获得了监管部门的支持。(证券时报)

2小时前

中信建投:白酒板块迎来周期底部配置机会

36氪获悉,中信建投指出,白酒产业“五底阶段”(政策底、库存底、动销底、批价底、产销底)与资本市场“三低一高”(预期低、估值低、公募持仓低、高分红)共振,结合近期市场策略相继落地,站在春节旺季来临之际,认为本轮白酒调整期拐点将至,资本市场预期先行,白酒板块迎来周期底部配置机会。

2小时前

CrowdStrike以7.4亿美元收购身份安全初创公司SGNL

网络安全提供商CrowdStrike周四宣布,将以近7.4亿美元的价格收购身份管理初创公司SGNL,以在人工智能网络攻击时代加强防御。该公司表示,此次收购将帮助CrowdStrike的Falcon云安全平台用户更好地管理人员和人工智能身份访问请求以及实时风险。该交易预计将于2027财年第一季度完成。(新浪财经)

2小时前

本页详细列出关于健恒药业的品牌信息,含品牌所属公司介绍,健恒药业所处行业的品牌地位及优势。
咨询